Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidS

计划入组 40 人 · 首次发布于 2026 年 4 月 30 日

Napoleon Trial: Optimal Treatment for Recurrent Haemorrhoidal Disease

计划入组 558 人 · 首次发布于 2019 年 9 月 24 日

RBL001/RBL002 Phase I Clinical Trial

计划入组 29 人 · 首次发布于 2012 年 9 月 12 日

RBL-1

RBL-001;RBL-002

RBL-001.1

RVL Pharmaceuticals, Inc.

United States

RVL Pharmaceuticals plc

United States

ABL Bio, Inc.

South Korea

RBL Secures Investment from Modi Ventures to Accelerate Biotech Venture Creation

Sentinel BioTherapeutics Launches with Novel IL-2 Immunotherapy Platform for Solid Tumors

Fecal Microbiota Therapy Shows 95% Success Rate in Preventing Recurrent C. difficile Infection